TrialBlood cancer journal2025

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

Jin Seok Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.